ClinicalTrials.gg
CompletedNCT06274372Updated Sep 24, 2024

The Effect of Flow-controlled Ventilation on Hemodynamic and Respiratory Parameters in Laparoscopic Surgeries

An interventional study of flow controlled ventilation and volume controlled ventilation in Laparoscopic Surgeries, sponsored by Derince Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-09-24.

Sponsored by Derince Training and Research Hospital · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

It is aimed to investigate the effect of flow controlled ventilation on intraoperative respiratory parameters and hemodynamic parameters in laparoscopic operations.

Read the detailed description

Study will begin after ethics committee approval and the patient's written and verbal consent .

Prospective observational studies will be conducted on patients over the age of 18 who will undergo laparoscopic surgery in the operating rooms. Patients who did not give verbal and written consent, emergency interventions, patients at risk of aspiration, patients with an ASA physical status above 3 and a diagnosis of COPD will be excluded.

Patients will be randomized and divided into two groups. Patients intraoperatively ventilated with a conventional ventilator (GE™ Avance™ CS2, VCV mode) Group 1, intraoperative ventilation Ventinova ( Evone®, Ventinova Medical, Eindhoven, the Netherlands, FCV mode) will be referred to as Group 2. Standard monitoring (ECG; SpO2, end tidal CO2,arterial blood pressure) will be applied to all patients. Anesthesia induction will be performed with propofol, fentanyl, rocuronium bromide as standard; In addition, anesthesia maintenance of the patients will be provided with propofol and remifentanil.

Respiratory parameters such as peripheral SpO2, PaCO2 value, peak airway pressure of each group will be recorded, and intraoperative hemodynamic parameters (systolic, diastolic, mean blood pressure, heart rate) of each group will be monitored and recorded.

Postoperative respiratory functions and length of hospital stay of all patients will be monitored and recorded.

02

Conditions studied

  • Laparoscopic Surgeries

Keywords

  • flow controlled ventilation
  • laparoscopy
03

In context

Lead sponsor

Derince Training and Research Hospital is the lead sponsor of 39 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: patients who will undergo laparoscopic surgeries, ASA 1,2,3 physical status

-

Exclusion Criteria:

  • patients who do not give verbal and written consent, emergency interventions, patients at risk of aspiration, patients with an above 3 and a diagnosis of
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Other
    control group

    patients ventilated with volume controlled ventilation

    Device: volume controlled ventilation

  • Experimental
    flow controlled ventilation

    patients ventilated with flow controlled ventilation

    Device: flow controlled ventilation

Interventions

  • Deviceflow controlled ventilation

    effects of flow controlled ventilation

  • Devicevolume controlled ventilation

    effects of volume controlled ventilation

06

What researchers measure

Primary outcomes

  1. effects of flow controlled ventilation on arterial pressure

    Arterial blood pressure in mmHg

    Time frame: intraoperatively

  2. effectcs of flow controlled ventiletion on endtidal CO2

    endtidal CO2 in mmHg

    Time frame: intraoperatively

  3. effects of flow controlled ventilation on mean arterial pressure

    mean arterial pressure change in percent

    Time frame: intraoperatively

  4. effects of flow controlled ventilation on heart rate

    heart rate in bpm

    Time frame: intraoperatively

  5. effectcs of flow controlled ventiletion on peak airway pressure

    peak airway pressure in cmH2O

    Time frame: intraoperatively

Secondary outcomes

  1. respiratory related complications

    rate of ventilator-associated pneumonia, rate of postoperative atelectasis, respiratory distress requiring reintubation by percentage.

    Time frame: intraoperative period and postoperative first week

07

Study locations

1 site
  • Kocaeli Derince Training and Research Hospital
    Derince, Kocaeli 41900, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2023 to primary completion in Aug 2024, 11 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 24, 2023
First posted
Feb 23, 2024
StartActual
Aug 7, 2023
Primary completionActual
Aug 6, 2024
CompletionActual
Aug 6, 2024
Last update
Sep 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06274372
Lead sponsor
Derince Training and Research Hospital
Responsible party
Nurseda Dundar (Principal Investigator, Derince Training and Research Hospital) — Principal investigator
First posted
Feb 23, 2024
Start date
Aug 7, 2023
Primary completion
Aug 6, 2024
Completion
Aug 6, 2024
Last update
Sep 24, 2024

Study contacts

Nurseda Dundar, MD
principal investigator · Kocaeli City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion